Opportunity ID: 310070

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-19-049
Funding Opportunity Title: New Research Directions that Advance the NHLBI Strategic Vision Normal Biology (R21 – Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.233 — National Center on Sleep Disorders Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Nov 01, 2018
Last Updated Date: Nov 01, 2018
Original Closing Date for Applications: Jan 07, 2022
Current Closing Date for Applications: Jan 07, 2022
Archive Date: Feb 12, 2022
Estimated Total Program Funding:
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Public housing authorities/Indian housing authorities
Independent school districts
State governments
Special district governments
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal governments (Federally recognized)
Small businesses
For profit organizations other than small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The development of more effective means for diagnosing and treating heart, lung, blood, and sleep (HLBS) disorders is often aided bya detailed understanding of normal biology, specifically the nature and operations of the molecular systems and cells that are affected by those diseases. ?Areas of?r?e?s?e?a?r?c?h? ?i?n?t?e?r?e?s?t?include? ?s?t?u?d?i?e?s? ?o?f? ?f?u?n?d?a?m?e?n?t?a?l? ?p?r?o?c?e?s?s?e?s? ?t?h?a?t?explain resilience the capability of some individuals to maintain or restore normal function despite aging or exposurethat causes disease in others.This Program Announcement FOA will support pilot studies by R01-funded investigators in areas of research that advance high priority studies of normal biology and resilience as described by Objective 1 of the NHLBI Strategic Vision.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-19-049.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00246033 Jan 16, 2019 May 24, 2020 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00259927 Jan 16, 2019 Jan 24, 2022 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00270233 Nov 16, 2021 Jan 07, 2022 View

Package 1

Mandatory forms

310070 RR_SF424_2_0-2.0.pdf

310070 PHS398_CoverPageSupplement_4_0-4.0.pdf

310070 RR_OtherProjectInfo_1_4-1.4.pdf

310070 PerformanceSite_2_0-2.0.pdf

310070 RR_KeyPersonExpanded_2_0-2.0.pdf

310070 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

310070 RR_Budget_1_4-1.4.pdf

310070 RR_SubawardBudget30_1_4-1.4.pdf

310070 PHS398_ModularBudget_1_2-1.2.pdf

310070 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

310070 RR_SF424_2_0-2.0.pdf

310070 PHS398_CoverPageSupplement_5_0-5.0.pdf

310070 RR_OtherProjectInfo_1_4-1.4.pdf

310070 PerformanceSite_2_0-2.0.pdf

310070 RR_KeyPersonExpanded_2_0-2.0.pdf

310070 PHS398_ResearchPlan_4_0-4.0.pdf

310070 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

310070 RR_Budget_1_4-1.4.pdf

310070 RR_SubawardBudget30_1_4-1.4.pdf

310070 PHS398_ModularBudget_1_2-1.2.pdf

310070 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

310070 RR_SF424_5_0-5.0.pdf

310070 PHS398_CoverPageSupplement_5_0-5.0.pdf

310070 RR_OtherProjectInfo_1_4-1.4.pdf

310070 PerformanceSite_4_0-4.0.pdf

310070 RR_KeyPersonExpanded_4_0-4.0.pdf

310070 PHS398_ResearchPlan_4_0-4.0.pdf

310070 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

310070 RR_Budget_3_0-3.0.pdf

310070 RR_SubawardBudget30_3_0-3.0.pdf

310070 PHS398_ModularBudget_1_2-1.2.pdf

310070 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T09:09:41-05:00

Share This Post, Choose Your Platform!

About the Author: